Reprieve Cardiovascular, Inc. (‘Reprieve’), a development stage company focused on pioneering an intelligent approach to…
Arboretum_JDMay 3, 2024
News
Success Begins Here
Dive into our most recent firm and portfolio updates
AtaCor Medical Closes $28M Series C Financing to Deliver Next Generation Extravascular ICD and Pacing Options for Cardiac Rhythm Management
AtaCor Medical Inc., a privately-held medical device company delivering the next generation of extravascular leads to…
Arboretum_JDApril 24, 2024
Fifth Eye Inc., a provider of intuitive real-time clinical analytics, announced the issuance of a…
Arboretum_JDApril 23, 2024
Allay Therapeutics’ Phase 2B Clinical Study Supports Ability of ATX101 To Deliver Four Weeks of Sustained Post-surgical Pain Relief
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management…
Arboretum_JDApril 11, 2024
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional…
Arboretum_JDApril 1, 2024
Flosonics Medical, a leader in wearable medical ultrasound, recently announced its Series C financing, raising…
Arboretum_JDMarch 20, 2024
Koya Medical recently announced topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective…
Arboretum_JDMarch 6, 2024
Virtual Incision Corporation announced the U.S. Food and Drug Administration (FDA) has granted marketing authorization of…
Arboretum_JDFebruary 26, 2024
